HUMATIN

This brand name is authorized in Austria, Canada, Estonia, Spain, Italy, Malta

Active ingredients

The drug HUMATIN contains one active pharmaceutical ingredient (API):

1 Paromomycin UNII 845NU6GJPS - PAROMOMYCIN SULFATE

Paromomycin is an aminoglycoside antibiotic derived from Streptomyces rimosus var paromomycinus, with amebicidal and antibacterial activity. Paromomycin binds specifically to the RNA oligonucleotide at the A site of bacterial 30S ribosomes, thereby causing misreading and premature termination of translation, thereby leading to inhibition of protein synthesis followed by cell death. Read about Paromomycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HUMATIN Capsule	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07AA06	Paromomycin	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02078759
Country: EE	Ravimiamet	Identifier(s): 1754311, 1754502
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 36795
Country: IT	Agenzia del Farmaco	Identifier(s): 016531016, 039333012
Country: MT	Medicines Authority	Identifier(s): AA565/47501